These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19958852)

  • 21. Assessment of bleeding events in clinical trials--proposal of a new classification.
    Serebruany VL; Atar D
    Am J Cardiol; 2007 Jan; 99(2):288-90. PubMed ID: 17223436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bleeding risk related to combined aspirin and other antithrombotic drug use in patients with acute coronary syndrome: prevention and therapy strategies].
    Li XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1057-9. PubMed ID: 21215136
    [No Abstract]   [Full Text] [Related]  

  • 24. Major bleeding: management and risk reduction in acute coronary syndromes.
    Cavender MA; Rao SV; Ohman EM
    Expert Opin Pharmacother; 2008 Aug; 9(11):1869-83. PubMed ID: 18627326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: do we need another bleeding definition? What does the Bleeding Academic Research Consortium definition have to offer?
    White HD
    Curr Opin Cardiol; 2011 Jul; 26(4):275-8. PubMed ID: 21499087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
    Mukherjee D; Eagle KA
    Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions.
    Diehm N; Pattynama PM; Jaff MR; Cremonesi A; Becker GJ; Hopkins LN; Mahler F; Talen A; Cardella JF; Ramee S; van Sambeek M; Vermassen F; Biamino G
    Eur J Vasc Endovasc Surg; 2008 Oct; 36(4):409-19. PubMed ID: 18692415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
    Wang TY; Ou FS; Roe MT; Harrington RA; Ohman EM; Gibler WB; Peterson ED
    Circulation; 2009 May; 119(18):2454-62. PubMed ID: 19398666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
    Murphy SA; Gibson CM; Morrow DA; Van de Werf F; Menown IB; Goodman SG; Mahaffey KW; Cohen M; McCabe CH; Antman EM; Braunwald E
    Eur Heart J; 2007 Sep; 28(17):2077-86. PubMed ID: 17600038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment.
    Boden H; van der Hoeven BL; Karalis I; Schalij MJ; Jukema JW
    J Intern Med; 2012 Jun; 271(6):521-36. PubMed ID: 22340431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.
    Melloni C; Peterson ED; Chen AY; Szczech LA; Newby LK; Harrington RA; Gibler WB; Ohman EM; Spinler SA; Roe MT; Alexander KP
    J Am Coll Cardiol; 2008 Mar; 51(10):991-6. PubMed ID: 18325437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.
    Van de Werf F
    Circulation; 2010 Jan; 121(1):5-7. PubMed ID: 20026787
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacologic management of insomnia in children and adolescents: consensus statement.
    Mindell JA; Emslie G; Blumer J; Genel M; Glaze D; Ivanenko A; Johnson K; Rosen C; Steinberg F; Roth T; Banas B
    Pediatrics; 2006 Jun; 117(6):e1223-32. PubMed ID: 16740821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of bleeding and blood transfusion in percutaneous coronary intervention.
    Rao SV
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S18-26. PubMed ID: 17917617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
    Deedwania P; Kosiborod M; Barrett E; Ceriello A; Isley W; Mazzone T; Raskin P
    Anesthesiology; 2008 Jul; 109(1):14-24. PubMed ID: 18580168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
    Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
    J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes.
    Budaj A; Eikelboom JW; Mehta SR; Afzal R; Chrolavicius S; Bassand JP; Fox KA; Wallentin L; Peters RJ; Granger CB; Joyner CD; Yusuf S;
    Eur Heart J; 2009 Mar; 30(6):655-61. PubMed ID: 18713759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report.
    Cohen M; Diez J; Fry E; Rao SV; Ferguson JJ; Zidar J; Levine G; Shani J
    J Invasive Cardiol; 2006 Dec; 18(12):617-39. PubMed ID: 17197714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005.
    Jackson K; Gersh BJ; Stockbridge N; Fleming TR; Temple R; Califf RM; Connolly SJ; Wallentin L; Granger CB;
    Am Heart J; 2008 May; 155(5):829-40. PubMed ID: 18440329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.